Doubts surrounding CVS's acquisition of Aetna haven’t faded away just yet. WSJheard explains why. WSJWhatsNow
Doubts surrounding CVS Health’s $70 billion acquisition haven’t faded away just yet.
The status of the integration of health insurer Aetna is the biggest risk for investors. After all, combining a health insurer with a retail pharmacy giant, not to mention a major drug-benefits administrator, is no simple task.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
CVS Health beats on fourth-quarter earnings and revenueCVS Health report Wednesday fiscal fourth-quarter earnings and revenue that beat Wall Street's expectations.
Les mer »
CVS Health posts fourth-quarter profitCVS Health Corp on Wednesday reported a quarterly profit compared with a year-ag...
Les mer »
EU chief rejects Johnson's idea of loose UK trade dealThe European Union's top official is dismissing British Prime Minister Boris Johnson's idea of brokering a loose trade deal with the EU.
Les mer »
Mercedes F1 team signal future intent with Ineos dealMercedes F1 boss Toto Wolff hailed a new chapter for a team who have won the last six drivers' and manufacturers' titles with Lewis Hamilton chasing his seventh career crown this season.
Les mer »
Bankers in Asia brace for a virus-related deal droughtBankers in Asia are bracing for a deal drought as efforts to limit the spread of...
Les mer »